Menu
Begin main content
Home Search
Result Type
Evidence Bundles
Product Line
Body Systems
Disease and Conditions
Target Population
Technologies, Therapies and Systems
Testing and Diagnostics
Publication Date
Clear all filters

Reports

We found 5993 result(s)

dapagliflozin (Forxiga )

Last Updated: April 8, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: dapagliflozin
Indications: Heart failure with reduced ejection fraction

  • Brand Name: Forxiga
  • Manufacturer: AstraZeneca Canada Inc.
  • Project Number: SR0642-000
  • Project Status: Received
  • Submission Type: New
Details

ixekizumab (Taltz )

Last Updated: April 7, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: ixekizumab
Indications: Ankylosing spondylitis

  • Brand Name: Taltz
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: SR0630-000
  • Project Status: Active
  • Submission Type: New Indication
Details

Iron (III) Isomaltoside 1000 (Monoferric)

Last Updated: April 9, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Iron (III) Isomaltoside 1000
Indications: iron deficiency anemia

  • Brand Name: Monoferric
  • Manufacturer: Pharmacosmos A/S
  • Project Number: SR0622-000
  • Project Status: Active
  • Submission Type: New
Details

tafamidis (Vyndaqel)

Last Updated: April 8, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: tafamidis
Indications: transthyretin-mediated amyloidosis

  • Brand Name: Vyndaqel
  • Manufacturer: Pfizer Canada
  • Project Number: SR0625-000
  • Project Status: Complete
  • Submission Type: New
Details

vortioxetine hydrobromide (Trintellix )

Last Updated: April 8, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: vortioxetine hydrobromide
Indications: Major depressive disorder (MDD), adults.

  • Brand Name: Trintellix
  • Manufacturer: Lundbeck Canada Inc.
  • Project Number: SR0611-000
  • Project Status: Complete
  • Submission Type: New
Details

safinamide (Onstryv)

Last Updated: April 6, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: safinamide
Indications: Parkinson's disease

  • Brand Name: Onstryv
  • Manufacturer: Valeo Pharma Inc.
  • Project Number: SR0617-000
  • Project Status: Active
  • Submission Type: New
Details

erenumab (Aimovig)

Last Updated: April 8, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: erenumab
Indications: Migraine

  • Brand Name: Aimovig
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0578-000
  • Project Status: Active
  • Submission Type: New
Details

New at CADTH - April 2020

Last Updated: April 9, 2020
Result type: Reports
Product Line: New at CADTH

News and Events CADTH is committed to serving you during the COVID-19 crisis. If you’re looking for credible answers to your COVID-19 questions, CADTH can help. We have created a website where you’ll find information from CADTH and other respected organizations related to COVID-19. As the COVID-19 situation is changing daily, we’ll be updating ...